Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Inovio Biomedical Corp (INO)  
$0.58 0.00 (0.00%) as of 4:30 Wed 1/24


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 169,410,000
Market Cap: 97.83(M)
Last Volume: 3,856,623 Avg Vol: 3,846,095
52 Week Range: $0.35 - $0.885
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    AMEX COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Inovio Pharmaceuticals is a biotechnology company focused on bringing the designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus. Co.'s DNA medicines pipeline is comprised of three types of product candidates: prophylactic DNA vaccines, therapeutic DNA immunotherapies, and DNA encoded monoclonal and bispecific antibodies, all of which utilize the two components of Co.'s integrated platform, SynCon® and CELLECTRA®. Co. is evaluating the feasibility of, conducting or planning clinical studies of its DNA medicines.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 37,076
Total Sell Value $0 $0 $0 $60,923
Total People Sold 0 0 0 3
Total Sell Transactions 0 0 0 5
End Date 2024-03-07 2023-12-05 2023-06-06 2022-06-06

   
Records found: 505
  Page 16 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Collins Morton Director   –       •      –    2014-08-21 4 B $10.01 $80,090 I/I 8,000 36,750 2.1     -
   Collins Morton Director   –       •      –    2014-08-20 4 B $9.72 $306,958 I/I 31,500 32,750 2.1     -
   Collins Morton Director   –       •      –    2014-08-20 4 B $9.71 $88,433 D/D 9,100 173,066 2.39     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2014-08-12 4 B $9.06 $2,263,750 I/I 250,000 1,750,000 2.66     -
   Sardesai Niranjan Chief Operating Officer   •       –      –    2014-08-12 4 B $8.70 $22,185 D/D 2,550 28,000 2.74     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2014-04-15 4 B $2.25 $56,250 D/D 25,000 5,965,809 2.81     -
   Collins Morton Director   –       •      –    2013-11-13 4 B $1.82 $117,422 I/I 64,500 75,000 2.1     -
   Collins Morton Director   –       •      –    2013-11-13 4 B $1.82 $345,895 D/D 190,000 655,864 2.39     -
   Bagarazzi Mark Chief Medical Officer   •       –      –    2013-04-16 4 B $0.56 $33,540 D/D 60,000 60,000 2.74     -
   Kim Jong Joseph Chief Executive Officer   •       •       •   2013-04-02 4 B $0.50 $45,180 D/D 90,000 11,940,809 3.23     -
   Cabrera Angel Director   –       •      –    2013-03-22 4 B $0.54 $21,592 D/D 40,000 115,000 2.39     -
   Sardesai Niranjan Chief Operating Officer   •       –      –    2013-03-20 4 B $0.53 $13,328 D/D 25,000 101,800 2.74     -
   Kim Jong Joseph Chief Executive Officer   •       •       •   2013-03-20 4 B $0.53 $31,680 D/D 60,000 11,850,809 3.23     -
   Collins Morton Director   –       •      –    2013-01-15 4 B $0.67 $66,940 I/I 100,000 50,000 2.1     -
   Kim Jong Joseph Chief Executive Officer   •       •       •   2013-01-04 4 GA $0.53 $79,485 I/I 150,000 134,130     -
   Kim Jong Joseph Chief Executive Officer   •       •       •   2013-01-04 4 GD $0.53 $79,485 D/D 150,000 11,790,809     -
   Marxe Austin W & Greenhouse David M 10% Owner   –       –       •   2012-12-03 4 S $0.55 $13,750 I/I (25,000) 3,919,706     -
   Marxe Austin W & Greenhouse David M 10% Owner   –       –       •   2012-11-30 4 S $0.55 $51,040 I/I (92,800) 3,944,706     -
   Marxe Austin W & Greenhouse David M 10% Owner   –       –       •   2012-11-29 4 S $0.54 $228,291 I/I (418,700) 4,037,506     -
   Marxe Austin W & Greenhouse David M 10% Owner   –       –       •   2012-11-28 4 S $0.57 $54,394 I/I (96,000) 4,456,206     -
   Marxe Austin W & Greenhouse David M 10% Owner   –       –       •   2012-11-27 4 S $0.49 $318,370 I/I (650,000) 4,552,206     -
   Marxe Austin W & Greenhouse David M 10% Owner   –       –       •   2012-11-26 4 S $0.47 $141,180 I/I (300,000) 5,202,206     -
   Marxe Austin W & Greenhouse David M 10% Owner   –       –       •   2012-11-23 4 S $0.47 $58,691 I/I (123,900) 5,502,206     -
   Marxe Austin W & Greenhouse David M 10% Owner   –       –       •   2012-11-21 4 S $0.47 $108,744 I/I (230,000) 5,626,106     -
   Marxe Austin W & Greenhouse David M 10% Owner   –       –       •   2012-11-20 4 S $0.47 $59,976 I/I (126,800) 5,856,106     -

  505 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 16 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed